AFPT-Club Phase 1
French association of the professionals of human and translational pharmacology
34, avenue des Champs-Elysées 75008 Paris 8ème, France
A founding member of
EUROPEAN FEDERATION FOR EXPLORATORY MEDICINES DEVELOPMENT
After the two first successful sessions, the AFPT-CP1 will run the third session of its pre-clinical and clinical safety in early development human trial course in cooperation with EUFEMED, its
After the two first successful sessions, the AFPT-CP1 will run the third session of its pre-clinical and clinical safety in early development human trial course in cooperation with EUFEMED, its European Federation, and Paris-Saclay University.
If you are interested by the programme, you please register:
Registration deadline: 05 March 2024
This training course will take place from 18-22nd of March 2024 in Saclay in the south of Paris (onsite).
It is a 5-day course on ‘Pre-Clinical and Clinical Safety in Early Development Human Trials’ recognized by Paris-Saclay University and EUFEMED, forming part of a diploma.
It follows the European ‘Pharmatrain’ syllabus, and a certification will be requested in the next future.
It is held in English and is intended for people working in the pharmaceutical industry and students who would like to know more on this sensitive topic.
Do not hesitate to speak of this advanced training to you colleagues who could be interested”
Course exclusively in English and in presential due to its interactive nature.
Minimal number of participants: 10
18 (Monday) 9 h 00 min - 22 (Friday) 16 h 00 min ECT
Site Henri Moissan Université Paris-Saclay
17 avenue des Sciences
AFPT - Le Club Phase 1